Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04134598
Title ExclUsive endocRine Therapy Or Partial Breast Irradiation for Women Aged >=70 Years Early Stage Breast Cancer (EUROPA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Azienda Ospedaliero-Universitaria Careggi
Indications

Her2-receptor negative breast cancer

Therapies

Tamoxifen

Letrozole

Anastrozole

Exemestane

Age Groups: senior
Covered Countries


No variant requirements are available.